Managers
The latest issue of Beauhurst’s The Deal shows that deal numbers in Britain’s start-ups and high growth companies in the first half of 2016 have fallen over 20 per cent compared to the second half of 2015.
The firm writes that it appears that the EU referendum and its impact on investor confidence has had a significant effect in the second quarter of this year. The number of deals completed on crowdfunding platforms has fallen for the first time on record, the firm says with deal numbers down 17 per cent against the second half of 2015.
Although fewer
Crowdfunding platform Seedrs has been named as Britain’s most active investor in private companies, ranked number one with 78 funded deals at the halfway point in 2016 according to a leading source of objective deep data on UK startups and scale ups.
The company writes that it is experiencing exponential year on year growth with 55 deals funded during the same period in 2015, and 43 deals funded in the first half of 2014.
Seedrs has a 50 per cent share of the UK equity crowdfunding market in 2016 with its closest competitor Crowdcube at 40 per cent while
Institutional and private client service provider JTC has acquired Arcange REIM in Luxembourg, enabling it to launch a new AIFM management company (ManCo) business as it continues to enhance its range of European alternative fund services.
The acquisition of Arcange REIM, which was one of the first Luxembourg based independent management companies to comply with the Alternative Investment Fund Managers Directive (AIFMD), was completed on 6 July following approval from the Commission de Surveillance du Secteur Financier (CSSF).
The new ManCo is called Global AIFM Solutions. A wholly owned subsidiary of JTC, Global AIFM Solutions will offer a fully AIFMD-compliant
Funds advised by private equity firm BC Partners and Canada’s Public Sector Pension Investment Board (PSP Investments) are to acquire a majority stake in Keter Group – a producer of resin consumer products – from its founders, the Sagol family.
The transaction, which is subject to customary approvals and is expected to close in the fourth quarter of 2016, will see the Sagol family retain a minority stake and reinvest alongside BC Partners.
Headquartered in Israel, Keter designs, engineers, produces and distributes a wide range of consumer goods worldwide across multiple categories, such as indoor and outdoor furniture, home accessories,
Shanghai Fosun Pharmaceutical (Fosun Pharma), a Chinese healthcare provider, is to acquire an 86 per cent stake in Indian generic injectable pharmaceutical products company Gland Pharma for up to USD1.26 billion.
The deal will see Fosun Pharma purchase all shares of Gland owned by KKR Floorline Investments in addition to shares purchased from other shareholders of the company.
PVN Raju, founder of Gland, and his son, Dr Ravi Penmetsa (pictured), will continue to be on the board, and Penmetsa will continue as managing director and CEO. The family will retain a stake in Gland.
Penmetsa says: "This transaction
G10 Capital, an affiliate of Lawson Conner, is to be appointed as an alternative investment fund manager (AIFM) by Gresham House Asset Management in order to provide alternative fund management services to LMS Capital.
The LMS portfolio, valued at just over GBP92 million, will form a key component of Gresham House's strategic equity division and leverage the private equity capability of the team.
The award of this investment mandate is in-line with the company's stated strategy to develop its alternative asset management platform, build AUM, both organically and through acquisition, and to grow earnings through asset management and performance
Private equity firms Aksìa Group and Alcedo are to sell Gimi, an Italian home care products provider, to FHCS (Freudenberg Home and Cleaning Solutions), the German owner of several brands including Vileda, Wettex and Marigold.
The transaction, which is subject to approval by antitrust authorities, is expected to complete by the end of the third quarter of this year.
Aksìa Group SGR, along with Alcedo SGR, invested in Gimi in October 2008 with the objective to support its growth, contributing professional management and industrial culture.
With a turnover of around EUR80 million (data from 2015) and over 320
MUFG Investor Services, the global asset servicing group of Mitsubishi UFJ Financial Group, is to acquire Guggenheim Investment’s 1940-Act mutual fund administration business, Rydex Fund Services.
The transaction is expected to close in the fourth quarter of 2016, subject to regulatory approvals and customary closing conditions.


When complete, the acquisition will provide MUFG Investor Services with a full service offering for investment managers, adding regulated 1940 Act mutual fund and exchange traded fund services expertise to its service proposition, which spans single manager, fund of hedge fund, private equity and real estate funds, pension funds and traditional asset managers.


Pulte Capital Partners has sold portfolio company Southern Air & Heat to MSouth Equity Partners, a private equity fund with USD1.3 billion under management across three funds.
Southern Air & Heat, based in the South-Eastern US, provides heating and air conditioning installation to the nation's largest homebuilders and is also a leading servicer and installer for over 70,000 homeowners across its South-Eastern target markets.
"Our team built Southern Air & Heat from just an idea to one of the largest heating and air conditioning platforms in the US. Southern Air was a highly successful investment for us, and we
IK Investment Partners’ IK 2007 Fund is to sell Vemedia Group, a producer and distributor of over the counter (OTC) drugs, food supplements and medical devices, to an entity ultimately owned by Charterhouse Capital Partners.
Charterhouse also owns La Coopération Pharmaceutique (Cooper), a French OTC drug manufacturer and distributor. The parties have agreed not to disclose the financial terms of the transaction.
The combination of Vemedia and Cooper will create a European market leader in the OTC drugs sector. The two businesses are complementary and will be well positioned to lead the further consolidation of the European OTC drugs
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
